Proteomic analysis of prolactinoma cells by immuno-laser capture microdissection combined with online two-dimensional nano-scale liquid chromatography/mass spectrometry

Proteome Science

Volumn 8, Issue , 2010, Pages

  Liu, Yingchao ^a,b   Wu, Jinsong ^b   Yan, Guoquan ^c   Hou, Ruiping ^d   Zhuang, Dongxiao ^b   Chen, Luping ^b   Pang, Qi ^a   Zhu, Jianhong ^b,c  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN;

ACCESS TO INFORMATION; ARTICLE; CANCER CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNO LASER CAPTURE MICRODISSECTION; LASER CAPTURE MICRODISSECTION; LIQUID CHROMATOGRAPHY; MALE; ONLINE ANALYSIS; PROLACTINOMA; PROTEIN DATABASE; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 77349116857     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-8-2     Document Type: Article

References (57)

1. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE. The prevalence of pituitary adenomas: A systematic review. Cancer 2006, 101(3):613-619.
2. Zhan X, Desiderio DM. A reference map of a human pituitary adenoma proteome. Proteomics 2003, 3:699-713. 10.1002/pmic.200300408, 12748949.
3. Desiderio DM, Zhan X. The human pituitary proteome: the characterization of differentially expressed proteins in an adenoma compared to a control. Cell Mol Biol 2003, 49:689-712.
4. Evans CO, Moreno CS, Zhan X, McCabe MT, Vertino PM, Desiderio DM, Oyesiku NM. Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses. Pituitary 2008, 11(3):231-245. 10.1007/s11102-007-0082-2, 18183490.
5. Schutze K, Lahr G. Identification of expressed genes by laser-mediated manipulation of single cells. Nat Biotechnol 1998, 16(8):737-742. 10.1038/nbt0898-737, 9702771.
6. Fend F, Emmert-Buck MR, Chuaqui R, Cole K, Lee J, Liotta LA, Raffeld M. Immuno-LCM: Laser Capture Microdissection of Immunostained Frozen Sections for mRNA Analysis. Am J Pathol 1999, 154(1):61-66. 1853427, 9916919.
7. Klose J, Kobalz U. Two-dimensional electrophoresis of proteins: An updated protocol and implications for a functional analysis of the genome. Electrophoresis 1995, 16(6):1034-1059. 10.1002/elps.11501601175, 7498127.
8. Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, Garvik BM, Yates JR. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 1999, 17(7):676-682. 10.1038/10890, 10404161.
9. Rabilloud T. Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2002, 2(1):3-10. 10.1002/1615-9861(200201)2:1<3::AID-PROT3>3.0.CO;2-R, 11788986.
10. Fournier ML, Gilmore JM, Martin-Brown SA, Washburn MP. Multidimensional separations-based shotgun proteomics. Chem Rev 2007, 107(8):3654-3686. 10.1021/cr068279a, 17649983.
11. Dowell JA, Frost DC, Zhang J, Li L. Comparison of Two-Dimensional Fractionation Techniques for Shotgun. Anal Chem 2008, 80(17):6715-6723. 10.1021/ac8007994, 2548321, 18680313.
12. Liu Y, Wu J, Liu S, Zhuang D, Wang Y, Shou X, Zhu J. Immuno-laser capture microdissection of frozen prolactinoma sections to prepare proteomic samples. Colloids and Surfaces B: Biointerfaces 2009, 71(2):187-193.
13. Lu Q, Murugesan N, Macdonald JA, Wu SL, Pachter JS, Hancock WS. Analysis of mouse brain microvascular endothelium using immuno-laser capture microdissection coupled to a hybrid linear ion trap with Fourier transform-mass spectrometry proteomics platform. Electrophoresis 2008, (12):2689-2695. 10.1002/elps.200700936, 18481836.
14. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4(5):P3. 10.1186/gb-2003-4-5-p3, 12734009.
15. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA. Laser capture microdissection. Science 1996, 274(5289):998-1001. 10.1126/science.274.5289.998, 8875945.
16. Lloyd RV. Advances in pituitary pathology: use of novel techniques. Front Horm Res 2004, 32:146-147. full_text, 15281345.
17. Espina V, Wulfkuhle JD, Calvert VS, VanMeter A, Zhou W, Coukos G, Geho DH, Petricoin EF, Liotta LA. Laser capture microdissection. Nat Protoc 2006, 1(2):586-603. 10.1038/nprot.2006.85, 17406286.
18. Mustafa D, Kros JM, Luider T. Combining laser capture microdissection and proteomics techniques. Methods Mol Biol 2008, 428:159-178. full_text, 18287773.
19. Domazet B, Maclennan GT, Lopez-Beltran A, Montironi R, Cheng L. Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer. Int J Clin Exp Pathol 2008, 1(6):475-488. 2480591, 18787684.
20. Morrison RS, Kinoshita Y, Johnson MD, Uo T, Ho JT, McBee JK, Conrads TP, Veenstra TD. Proteomic analysis in the neurosciences. Mol Cell Proteomics 2002, 1:553-560. 10.1074/mcp.R200004-MCP200, 12376570.
21. Zhan X, Evans CO, Oyesiku NM, Desiderio DM. Proteomics and transcriptomics analyses of secretagogin down-regulation in human non-functional pituitary adenomas. Pituitary 2003, 6(4):189-202. 10.1023/B:PITU.0000023426.99808.40, 15237930.
22. Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, Oyesiku NM. Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 2005, 65(22):10214-10222. 10.1158/0008-5472.CAN-05-0884, 16288009.
23. Asa SL, Ezzat S. Genetics and proteomics of pituitary tumors. Endocrine 2005, 28(1):43-47. 10.1385/ENDO:28:1:043, 16311409.
24. Liu ZX, Liu YS, Fang WH, Chen W, Li C, Xiao ZQ. Establishment of differential expression profiles from invasive and non-invasive pituitary adenomas. J Cent South Univ (Med Sci) 2009, 34(07):569-575.
25. Zhan X, Desiderio DM. Comparative proteomics analysis of human pituitary adenomas: Current status and future perspectives. Mass Spectrometry Reviews 2005, 24(6):783-813. 10.1002/mas.20039, 15495141.
26. Jin L, Tsumanuma I, Ruebel KH, Bayliss JM, Lloyd RV. Analysis of homogeneous populations of anterior pituitary folliculostellate cells by laser capture microdissection and reverse transcription-polymerase chain reaction. Endocrinology 2001, 142(5):1703-1709. 10.1210/en.142.5.1703, 11316732.
27. Zang L, Palmer TD, Hancock WS, Sgroi DC, Karger BL. Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling. J Proteome Res 2004, 3(3):604-612. 10.1021/pr034131l, 15253443.
28. Moulédous L, Hunt S, Harcourt R, Harry JL, Williams KL, Gutstein HB. Proteomic analysis of immunostained, laser-capture microdissected brain samples. Electrophoresis 2003, 24(1-2):296-302. 10.1002/elps.200390026, 12652601.
29. Tomazella GG, da Silva I, Laure HJ, Rosa JC, Chammas R, Wiker HG, de Souza GA, Greene LJ. Proteomic analysis of total cellular proteins of human neutrophils. Proteome Sci 2009, 7(1):32. 10.1186/1477-5956-7-32, 19719850.
30. Corthals GL, Wasinger VC, Hochstrasser DF, Sanchez JC. The dynamic range of protein expression: A challenge for proteomic research. Electrophoresis 2000, 21:1104-1115. 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.0.CO;2-C, 10786884.
31. Fountoulakis M, Tsangaris G, Oh JE, Maris A, Lubec G. Protein profile of the HeLa cell line. J Chromatogr A 2004, 1038:247-265. 10.1016/j.chroma.2004.03.032, 15233540.
32. Allen MJ, Howard JA, Lilley KS, Wilson WH. Proteomic analysis of the EhV-86 virion. Proteome Sci 2008, 6-11. 2270821, 18234112.
33. de Godoy LM, Olsen JV, Cox J, Nielsen ML, Hubner NC, Fröhlich F, Walther TC, Mann M. Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast. Nature 2008, 455(7217):1251-1254. 10.1038/nature07341, 18820680.
34. Craven RA, NTotty N, Harnden P, Selby PJ, Banks RE. Laser Capture Microdissection and Two-Dimensional Polyacrylamide Gel Electrophoresis. Am J Pathol 2002, 160:815-822. 1867173, 11891180.
35. Vidal S, Kovacs K, Horvath E, Rotondo F, Kuroki T, Lloyd RV, Scheithauer BW. Topoisomerase II alpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior. Mod Pathol 2002, 15(11):1205-1212. 10.1097/01.MP.0000036342.73003.55, 12429800.
36. Korbonits M, Chahal HS, Kaltsas G, Jordan S, Urmanova Y, Khalimova Z, Harris PE, Farrell WE, Claret FX, Grossman AB. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors. J Clin Endocrinol Metab 2002, 87:2635-2643. 10.1210/jc.87.6.2635, 12050228.
37. Thapar K, Scheithauer B, Kovacs K, Pernicone PJ, Laws ER. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 1996, 38:765-769. 10.1097/00006123-199604000-00027, 8692397.
38. Thapar K, Kovacs K, Scheithauer B, Stefa-neanu L, Horvath E, Pernicone JP, Murray D, Laws RE. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 anti-body. Neurosurgery 1996, 38:99-107. 10.1097/00006123-199601000-00024, 8747957.
39. Jordan S, Lidhar K, Korbonits M, Lowe DG, Grossman AB. Cyclin D and cyclin E expression in normal and adenomatous pituitary. Eur J Endocrinol 2000, 143(1):R1-6. 10.1530/eje.0.143R001, 10870044.
40. Turner HE, Nagy Z, Sullivan N, Esiri MM, Wass JA. Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland. Clin Endocrinol (Oxf) 2000, 53(3):337-344. 10.1046/j.1365-2265.2000.01088.x, 10971451.
41. Kimura SH, Ikawa M, Ito A, Okabe M, Nojima H. Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery. Oncogene 2001, 20(25):3290-3300. 10.1038/sj.onc.1204270, 11423978.
42. Zhang L, Gjoerup O, Roberts TM. The serine/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling. Proc Natl Acad Sci USA 2004, 101(28):10296-10301. 10.1073/pnas.0403175101, 478566, 15240878.
43. Chen X. Cyclin G: a regulator of the p53-Mdm2 network. Dev Cell 2002, 2(5):518-519. 10.1016/S1534-5807(02)00182-X, 12015958.
44. Chaudhri M, Scarabel M, Aitken A. Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo. Biochem Biophys Res Commun 2003, 300(3):679-685. 10.1016/S0006-291X(02)02902-9, 12507503.
45. Dougherty MK, Morrison DK. Unlocking the code of 14-3-3. J Cell Sci 2004, 117(Pt 10):1875-1884. 10.1242/jcs.01171, 15090593.
46. Takahashi Y. The 14-3-3 proteins: gene, gene expression, and function. Neurochem Res 2003, 28(8):1265-1273. 10.1023/A:1024296932670, 12834267.
47. Gouraud SS, Yao ST, Heesom KJ, Paton JF, Murphy D. 14-3-3 proteins within the hypothalamic-neurohypophyseal system of the osmotically stressed rat: transcriptomic and proteomic studies. J Neuroendocrinol 2007, 19(11):913-922. 10.1111/j.1365-2826.2007.01604.x, 17927670.
48. Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC, Scheithauer BW. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999, 154(2):313-323. 1850003, 10027389.
49. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature 1992, 359(6393):295-300. 10.1038/359295a0, 1406933.
50. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K. Mice lacking p27 (Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996, 85(5):707-720. 10.1016/S0092-8674(00)81237-4, 8646779.
51. Korbonits M, Chahal HS, Kaltsas G, Jordan S, Urmanova Y, Khalimova Z, Harris PE, Farrell WE, Claret FX, Grossman AB. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors. J Clin Endocrinol Metab 2002, 87(6):2635-2643. 10.1210/jc.87.6.2635, 12050228.
52. Nakabayashi H, Sunada J, Hara M. Immunohistochemical analysis of cell cycle-related proteins, apoptosis, and proliferation in pituitary adenomas. J Histochem Cytochem 2001, 49(9):1193-1194.
53. Quereda V, Malumbres M. Cell cycle control of pituitary development and disease. J Mol Endocrinol 2009, 42(2):75-86. 10.1677/JME-08-0146, 18987159.
54. Nakamura M, Sakurai Y, Takeda, Toda T. Comparative proteomics of flotillin-rich Triton X-100-insoluble lipid raft fractions of mitochondria and synaptosomes from mouse brain. J Electrophor 2005, 49(4):77-83.
55. Liu H, Finch JW, Luongo JA, Li GZ, Gebler JC. Development of an online two-dimensional nano-scale liquid chromatography/mass spectrometry method for improved chromatographic performance and hydrophobic peptide recovery. J Chromatogr A 2006, 1135(1):43-51. 10.1016/j.chroma.2006.09.030, 17027011.
56. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74(20):5383-5392. 10.1021/ac025747h, 12403597.
57. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75(17):4646-4658. 10.1021/ac0341261, 14632076.